Advanced search

Authors whose works are in public domain in at least one jurisdiction

List of works by Sharon B Love

1-13 of 13 results

View this query on the Wikidata Query Service
c-erbB-2 protein overexpression in breast cancer is a risk factor in patients with involved and uninvolved lymph nodes

scientific article published on March 1, 1991
Transforming growth factor-β isoform expression in human ovarian tumours

scientific article published on December 1, 1997
The management of recurrent acute myelogenous leukaemia at a single centre over a fifteen‐year period

scientific article published on 01 March 1993
PACMEL: A phase 1 dose escalation trial of trametinib (GSK1120212) in combination with paclitaxel

scientific article published on December 24, 2014
How important is peritoneal involvement in rectal cancer? A prospective study of 331 cases

scientific article published on 01 November 2010
Protocol for Combined Analysis of FOXFIRE, SIRFLOX, and FOXFIRE-Global Randomized Phase III Trials of Chemotherapy +/- Selective Internal Radiation Therapy as First-Line Treatment for Patients With Metastatic Colorectal Cancer.

scientific article
Mitoxantrone and cytosine arabinoside as treatment for acute myeloblastic leukemia in older patients

scientific article published on July 1, 1995
Access to routinely collected health data for clinical trials - review of successful data requests to UK registries

scientific article published on 12 May 2020
Use of routinely collected health data in randomised clinical trials: comparison of trial-specific death data in the BOSS trial with NHS Digital data

scientific article published on 26 September 2021
Access to routinely collected health data for clinical trials – review of successful data requests to UK registries

Short term therapy (STT) for acute myelogenous leukaemia (AML)

scientific article published on January 1, 1992
Monitoring in practice - How are UK academic clinical trials monitored? A survey

scientific article published on 09 January 2020
Practicalities in running early-phase trials using the time-to-event continual reassessment method (TiTE-CRM) for interventions with long toxicity periods using two radiotherapy oncology trials as examples

scientific article published on 22 June 2020

Paulina is supported by:

About Paulina

Help